Nicholas M. Barnes

11.4k total citations · 1 hit paper
147 papers, 7.7k citations indexed

About

Nicholas M. Barnes is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Nicholas M. Barnes has authored 147 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 65 papers in Cellular and Molecular Neuroscience and 18 papers in Biological Psychiatry. Recurrent topics in Nicholas M. Barnes's work include Neurotransmitter Receptor Influence on Behavior (50 papers), Receptor Mechanisms and Signaling (40 papers) and Neuroscience and Neuropharmacology Research (36 papers). Nicholas M. Barnes is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (50 papers), Receptor Mechanisms and Signaling (40 papers) and Neuroscience and Neuropharmacology Research (36 papers). Nicholas M. Barnes collaborates with scholars based in United Kingdom, United States and Italy. Nicholas M. Barnes's co-authors include Trevor Sharp, B. Costall, R.J. Naylor, Janine M. Barnes, Rachel Upthegrove, Jian Ge, John Gordon, Robert J. Naylor, Lucinda J. Steward and M.B. Tyers and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Nicholas M. Barnes

144 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of central 5-HT receptors and their function

1999 2.6k citations Nicholas M. Barnes et al. Neuropharmacology profile →

Peers

Countries citing papers authored by Nicholas M. Barnes

Since Specialization

Citations

This map shows the geographic impact of Nicholas M. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas M. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas M. Barnes more than expected).

Fields of papers citing papers by Nicholas M. Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas M. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas M. Barnes. The network helps show where Nicholas M. Barnes may publish in the future.

Co-authorship network of co-authors of Nicholas M. Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas M. Barnes. A scholar is included among the top collaborators of Nicholas M. Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas M. Barnes. Nicholas M. Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Structure–Activity Relationship Study of Novel Positive Allosteric Modulators for the δ-Opioid Receptor 2025 ·ACS Chemical Neuroscience ·(unknown), Vi Pham, (unknown), Nicholas M. Barnes, Arisbel B. Gondin, Arthur Christopoulos, Daniel P. Poole, Simona Carbone, David M. Thal, Manuela Jörg, Ben Capuano, Céline Valant, Peter J. Scammells	1
2	Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Heather Wood, (unknown), Heping Xu, Timothy J. Lyons, Nicholas M. Barnes, Parth Narendran, Janet M. Lord, Saaeha Rauz, Ian G. Ganley, Tim M. Curtis, Graham R. Wallace, José R. Hombrebueno	9
3	Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity 2023 ·Brain Behavior and Immunity ·Paris Alexandros Lalousis, Lianne Schmaal, Stephen J. Wood, Renate Reniers, Vanessa Cropley, Andrew Watson, Christos Pantelis, John Suckling, Nicholas M. Barnes, Carmine M. Pariante, Peter B. Jones, Eileen M. Joyce, Thomas R. E. Barnes, Stephen M. Lawrie, Nusrat Husain, Paola Dazzan, J.F.W. Deakin, Cynthia Shannon Weickert, Rachel Upthegrove	16
4	Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis 2023 ·BMJ Open ·Éimear M. Foley, Siân Lowri Griffiths, (unknown), Jack Rogers, Fabiana Corsi‐Zuelli, (unknown), (unknown), Martin Wilson, Muzaffer Kaşer, Graham K. Murray, J.F.W. Deakin, Deepak R. Jadon, John Suckling, Nicholas M. Barnes, Rachel Upthegrove, Golam M. Khandaker	8
5	SPAK and OSR1 kinases bind and phosphorylate the β2-Adrenergic receptor 2020 ·Biochemical and Biophysical Research Communications ·(unknown), Gillian Grafton, Nicholas M. Barnes, Youcef Mehellou	2
6	Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT 2019 ·SHILAP Revista de lepidopterología ·J.F.W. Deakin, John Suckling, Paola Dazzan, Eileen M. Joyce, Stephen M. Lawrie, Rachel Upthegrove, Nusrat Husain, Imran B. Chaudhry, Graham Dunn, Peter B. Jones, (unknown), Shôn Lewis, Thomas R. E. Barnes, Steven Williams, Carmine M. Pariante, Emma Knox, Richard Drake, Richard Smallman, Nicholas M. Barnes	7
7	Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions 2019 ·SHILAP Revista de lepidopterología ·William J. Scotton, Lisa J. Hill, Adrian Williams, Nicholas M. Barnes	124
8	082 Safety of ondansetron in a case series of patients with a predisposition to seizures 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), (unknown), Tom Hayton, Nicholas M. Barnes	0
9	Sustained release of decorin to the surface of the eye enables scarless corneal regeneration 2018 ·npj Regenerative Medicine ·Lisa J. Hill, Richard J. A. Moakes, Chairut Vareechon, (unknown), (unknown), Kristian Brock, Gurpreet Chouhan, (unknown), Serena Abbondante, Richard L. Williams, Nicholas M. Barnes, Eric Pearlman, Graham R. Wallace, Saaeha Rauz, Ann Logan, Liam M. Grover	50
10	Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death 2011 ·Investigational New Drugs ·Agata M. Wasik, Michael Gandy, Matthew J. McIldowie, Michelle J. Holder, Anita Chamba, (unknown), (unknown), Stephen P. Young, Dagmar Scheel‐Toellner, Martin J.S. Dyer, Nicholas M. Barnes, Matthew Piggott, John Gordon	5
11	Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome 2010 ·Bioorganic & Medicinal Chemistry Letters ·David D. Manning, Christopher L. Cioffi, Alexander Usyatinsky, (unknown), (unknown), (unknown), Zhenjun Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Svetlana V. Dobritsa, (unknown), William G. Earley, (unknown), Catherine Brady, Nicholas M. Barnes, Marlene L. Cohen, Peter R. Guzzo	9
12	Lymphocytes transport serotonin and dopamine: agony or ecstasy? 2003 ·Trends in Immunology ·John Gordon, Nicholas M. Barnes	116
13	Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain 1999 ·Neuroscience Letters ·(unknown), Nicholas M. Barnes	11
14	Distribution of S(−)-zacopride-insensitive []R(+)-zacopride binding sites in the rat brain and peripheral tissues 1997 ·European Journal of Pharmacology ·Jian Ge, Janine M. Barnes, (unknown), Nicholas M. Barnes	10
15	Autoradiographic Mapping of Brain 5-HT2A Binding Sites in P and in AA Alcohol-Preferring Rats 1997 ·Brain Research Bulletin ·Roberto Ciccocioppo, Jian Ge, Nicholas M. Barnes, Steven J. Cooper	13
16	Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-S-zacopride and [3H]granisetron 1993 ·Biochemical Pharmacology ·Janine M. Barnes, Nicholas M. Barnes	17
17	Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm 1992 ·Neuroreport ·(unknown), Nicholas M. Barnes, B. Costall, H. Gozlan, M. Hamon, M.E. Kelly, Deborah Murphy, Robert J. Naylor	17
18	The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex 1990 ·Brain Research Bulletin ·Nicholas M. Barnes, B. Costall, (unknown), Zola P. Horovitz, James W. Ironside, R.J. Naylor, Timothy J. Williams	5
19	Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro 1989 ·Brain Research ·Janine M. Barnes, Nicholas M. Barnes, B. Costall, Zola P. Horovitz, R.J. Naylor	77
20	Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret 1988 ·Neuropharmacology ·J. A. Barnes, Nicholas M. Barnes, B. Costall, R.J. Naylor, F TATTERSALL	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact